SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-162532
Filing Date
2018-05-14
Accepted
2018-05-14 16:06:52
Documents
51
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d574986d10q.htm 10-Q 582559
2 EX-31.1 d574986dex311.htm EX-31.1 6489
3 EX-31.2 d574986dex312.htm EX-31.2 6049
4 EX-32.1 d574986dex321.htm EX-32.1 4452
11 GRAPHIC g574986g0508193440172.jpg GRAPHIC 25267
  Complete submission text file 0001193125-18-162532.txt   2359950

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT drna-20180331.xml EX-101.INS 334311
6 XBRL TAXONOMY EXTENSION SCHEMA drna-20180331.xsd EX-101.SCH 30293
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drna-20180331_cal.xml EX-101.CAL 43450
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drna-20180331_def.xml EX-101.DEF 75036
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE drna-20180331_lab.xml EX-101.LAB 220573
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drna-20180331_pre.xml EX-101.PRE 151747
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36281 | Film No.: 18830612
SIC: 2834 Pharmaceutical Preparations